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Abstract
Validation of a Screening Tool for Pediatric Obstructive Sleep Apnea: A Pilot Study
By: Julia Giardina
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
in Dentistry at Virginia Commonwealth University.
Virginia Commonwealth University, May 3, 2021
Thesis Advisor: Eser Tufekci, D.D.S., M.S., Ph.D., M.S.H.A.
DEPARTMENT OF ORTHODONTICS
Purpose: The purpose of this study was to evaluate the Pediatric-Modified-STOP-Bang (PMSTOP-Bang) as a screening tool to assess sleep related breathing disorders (SRBD) within a
pediatric population. The specific aims of this study were: 1) compare the PM-STOP-Bang scores
with those from the validated Pediatric Sleep Questionnaire (PSQ), 2) determine the ability of the
PM-STOP-Bang and the PSQ screening tools to accurately detect children of high risk for SRBD
from a one-night home sleep apnea test (HSAT).
Methods: Orthodontic patients were screened using the PM-STOP-Bang at VCU Graduate Clinic.
Patients (n=10) who were recruited and enrolled. Five were determined to be at high risk based on
PM-STOP Bang score. After enrollment, a guardian completed the PSQ, the Pediatric Symptom
checklist (PSC), and the child completed a one-night HSAT. Five age-matched controls were
enrolled.
Results: Scores of PM-STOP-Bang compared to PSQ related to a sensitivity for the PM-STOPBang of 67% (95% CI: 29-100%) and a specificity of 75% (95% CI: 33-100%). Comparing the
PM-STOP-Bang to the HSAT results, the PM-STOP-Bang had a sensitivity of 100% (95% CI:
100%, 100%) and a specificity of 71% (95% CI: 38%, 100%). The PSQ sensitivity was 67% (95%
CI: 13%, 100%) and specificity 43% (95% CI: 6%, 80%).
Conclusions: The PM-STOP-Bang achieved a greater sensitivity and specificity than the PSQ in
identifying children at high risk for obstructive sleep apnea when cases were confirmed with the
HSAT. A future study with a larger sample size is needed to validate the PM-STOP-Bang.

Introduction
Sleep-related breathing disorders (SRBD) are a diagnostic category that reflect an array
of obstructive phenomena and conditions ranging from primary snoring, upper airway resistance
syndrome, and obstructive sleep apnea (OSA).1 OSA is characterized by prolonged, partial or
complete upper airway obstruction that disrupts normal ventilation and normal sleep in patients.2
The constricted airway and resultant reduced airflow cause an increased respiratory effort.
Furthermore, a relative decrease in serum oxygen may initial cortical arousal from sleep: The
activation of sympathetic nervous system can then lead to increased heart rate, blood pressure
and arrhythmia.3
OSA affects both adults and children, but there are differences in the symptoms,
prevalence, etiology and pathophysiology depending on the age of the patient. According to the
American Sleep Apnea Association, 1-4% of children suffer from sleep apnea.4 The etiology of
pediatric obstructive sleep apnea (POSA) is complex and multifactorial; there is evidence that
pathogenesis is associated with neuromuscular tone dysfunction and upper airway constrictions,
most often due to adenotonsillary hypertrophy.5
Symptoms of POSA range from chronic snoring, increased respiratory effort at breathing,
daytime fatigue and sleepiness, nocturnal enuresis, irritability, and behavioral and neurocognitive
changes.6 In severe cases on untreated or poorly controlled POSA, clinical sequelae include
failure to thrive, cor pulmonale, pulmonary hypertension, and other cardiovascular
complications.5 Furthermore, about 25% of children diagnosed with Attention Deficient

1

Hyperactivity Disorder (ADHD) have symptoms of POSA. In these children, learning difficulties
and behavior problems attributed to ADHD are actually the result of sleep problems.
Unfortunately, eighty percent of adult men and ninety percent of women with OSA
remain undiagnosed despite available screening tools. Appropriate diagnosis of POSA or SRBD
is even more elusive in children because of less distinct signs and symptoms.7 Therefore, the
diagnosis of POSA and SRBD tends to be frequently delayed or missed.
Diagnostic confirmation of SRBD is carried out by a sleep medicine physician through
in-center polysomnography (PSG), or out-of-center tests (OCST).6 The PSG sleep study
involves recording of a variety of body functions including electrical activity of the brain, eye
movements, muscle activity, heart rate, breathing patterns, air flow and blood oxygen levels.
PSG is the “gold standard” for the diagnosis of OSA. During sleep, the number of apneas and
hypopneas is recorded and apnea-hypopnea index (AHI) is calculated by determining the number
of events per hour. AHI is then used to determine the severity of sleep apnea. In adults, while an
index of less than 5 is considered normal, values higher than 30 indicate severe sleep apnea.2
An in-center PSG sleep study is labor-intensive: it causes discomfort and inconvenience
to patients and their families. In addition, it has around a 6-month wait time between referral,
evaluation, and diagnosis.8 There are other limitations with the use of PSG including the high
cost and lack of access to the study centers, which usually only occur at integrative medical
centers.9
An home sleep apnea test (HSAT) is a type of OCST which includes 4-7 channels of
monitoring but does not include electroencephalogram.2 The home-based PSG studies have
advantages in that they are simplified and performed in the subject’s natural sleep environment.
2

In addition, there is no wait time, and the equipment is more readily available.10 However,
because a home test only evaluates breathing, results may be inconclusive or false negative. In
the literature, sensitivity and specificity of the home-based studies are reported to range from 86100% and 64-100%, respectively.11
As mentioned earlier, a PSG at a sleep center is the standard method for the diagnosis of
OSA. However, today HSATs are popular because of their simplicity, cost-effectiveness, and
reliability.12 The NOX-T3 portable device is a type of HSAT monitor that received the Food and
Drug Administration’s acceptance for an off-site sleep testing service in 2008. The monitor is
approved for use on patients two years of age and older.13
Previous studies have shown that the HSAT using the NOX-T3 had a good agreement
compared to PSG with a high degree of sensitivity for detecting OSA.12 Moderate to severe OSA
was diagnosed with 93% sensitivity and 85% specificity with the use of the NOX-T3. The
simultaneous in-laboratory T3 study showed an even higher agreement with PSG (100%
sensitivity and 94% specificity) highlighting that the differences found between the home NOXT3 study and in-lab PSG are mainly due to the night-to-night variability and differences in sleep
environment.12 While all of this information regarding HSATs is hopeful and reduces barriers
relative to in-center PSG, patients must still be referred to a sleep physician once they are
identified as high-risk for OSA.
As discussed previously, POSA can be serious and life-threatening in children.
According to Jennum et al.14 early diagnosis of POSA in pediatric population is of paramount
importance. However, OSA remains heavily undiagnosed despite well-documented symptoms
and complications.15 Nevertheless, prescribing every child over the age of five with an in-center
3

PSG is not a realistic or valid approach for the diagnosis OSA and SRBD. Using an HSAT
would be a more convenient option, but only board-certified physicians may administer and
interpret the data. Another alternative and cost-effective option is for health care providers to
administer screening questionnaires to identify children of high risk. Non-PSG screening tools
obtaining information on the pathophysiology, symptoms, and typical craniofacial presentations
offer a good alternative to the traditional invasive in-lab test. However, the major limitation in
using non-PSG screening tools is that they are insufficient when used alone to definitively
diagnosis OSA. Nevertheless, they can guide the clinician when it is appropriate to make a
referral to a sleep specialist who can diagnose sleep apnea.
There are many non-PSG screening tools that have been developed in an effort to screen
for SRBD in children, however the Pediatric Sleep Questionnaire (PSQ) is the only instrument
that has been validated to use pediatric patients.8 The PSQ is a 22-item survey administered to
explore prominent symptoms associated with SRBD. There are questions regarding behavior,
breathing, sleepiness, and other important signs of the disorder. When compared with PSG data,
PSQ instrument has been shown to have a sensitivity of 85% and a specificity of 87% for
identifying SRBD in children 2-18.16 While the PSQ has the best diagnostic accuracy, its
shortcomings does not allow for replacing the current gold standard, PSG.
Another non-PSG screening tool that can be used as an adjunct in assessment of SRDBs
is the Pediatric Symptom Checklist (PSC). The PSC is a psychosocial one-page screening tool
aimed to assess signs and behavior to allow for appropriate interventions.17 This well-established
and validated questionnaire can be used as a supplement to specifically address the behavioral
components of the disorder, but is not intended to use solely for the diagnosis SRDBs.
4

There has been some research to show that questionnaires, physical examinations or both
could be useful for reliably diagnosing SRDB. In 2008, Chung et al.18 developed and validated a
STOP-Bang questionnaire as a screening tool for OSA in adult patients 18 years and older. This
questionnaire consists of four “yes” or “no” questions: “Do you Snore loudly?”, “Do you feel
Tired during the daytime?”, “Has anyone Observed you stop breathing during sleep?”, and “Do
you have high blood Pressure?” Furthermore, body mass index (B), age (A), neck size (N), and
gender (G) were found to have a sensitivity of 83.6%, 92.9% and 100% for mild, moderate and
severe OSA, respectively.18
Due to a need for a non-PSG screening tool that takes into account both physical and
behavioral presentations in high-risk children for POSA and SRBD, Chiang et al.19 modified the
STOP-Bang instrument to accommodate pediatric populations. The Pediatric Modified-STOPBang (PM-STOP-Bang) was revised after the study to include the presence of snoring (S),
tonsillar hypertrophy (T), observed obstruction (O), the BMI percentage for age and gender, the
age at diagnosis (A), the presence of neuromuscular disorder (N), and the presence of genetic/
congenital disorder (G). The screening tool proved to be predictive of pediatric OSA, but needed
more exploration of ethnicity factors, presence of asthma, and family history of OSA.19
Although, it has not been validated to use for POSA and SRBD screening, it provides merit in its
ability to identify the physical and behavioral manifestations of the disorder.
According to a recent study, the prevalence of SRBD in orthodontic patients is 10.8%,
which is much higher than the prevalence seen in a normal healthy pediatric population (1-4%).
(Abtahi, 2019) One of the major reasons for high prevalence in orthodontic patients is because of
the known craniofacial manifestations of POSA and SRBD that result in malocclusion.
5

Currently, the PSQ is the only recommended screening tool to be used by dentists and
orthodontists to identify pediatric SRBD.20 However, the PSQ does not take into account
physical examination, such as tonsillar hypertrophy.8
The specialty of orthodontics provides much more value to patients than simply aligning
teeth and this is evident with the current role of orthodontists in the management of sleep apnea.
In 2019, The American Association of Orthodontists released a white paper discussing the
prevalence of OSA and a significant role the orthodontist can play in early diagnosis.2
Furthermore, orthodontists can easily administer screening for OSA in their broad patient
population (child, adolescents, adults) and can therefore be a valuable player in the
multidisciplinary management of OSA.
Also, orthodontists are experts in the anatomy and development of craniofacial complex
and are skilled to screen for craniofacial morphologies associated with POSA, such as steep
mandibular plane, retrusive chin, inferior hyoid bone, narrow maxilla, long facial height,
tendency for anterior open bite, and decreased pharyngeal airway.5 These craniofacial features
are well-established risk factors for SRDB and may be easily assessed from routine orthodontic
records. Moreover, orthodontists have a long history of working with other specialists in
medicine and dentistry to provide collaborative efforts for their patients with specific needs (such
as cleft lip, and pediatric patients).2 Finally, the frequency of routine orthodontic visits and
regular updates to health history forms also strengthen the ability of orthodontists to fill this role
as early providers. Therefore, the availability of a diagnostic tools, such as a screening
questionnaire, may help orthodontists to identify patients at risk and make early referrals to the
appropriate physician.
6

Since there is not a concise questionnaire that explores both physical and behavioral
manifestations for pediatric patients, the PM-STOP-Bang screening tool addressing these
components of SRBD may therefore be successfully used for the detection of POSA in children.
The purpose of the study was to evaluate the PM-STOP-Bang instrument as a valid
screening tool to assess SRBD in children. Specifically, the aims of this study were: 1) to
compare the PM-STOP-Bang scores with the results of the Pediatric Sleep Questionnaire (PSQ),
2) to determine the ability of the PM-STOP-Bang and the PSQ to detect patients at high risk for
POSA by confirming the disorder with a one-night home sleep apnea test (HSAT).

7

Methods
Prior to starting the study, ethical approval was obtained from the institutional review
board (IRB) of Virginia Commonwealth University (IRB ID: HM20017418). The study sample
consisted of children seeking treatment for malocclusion at VCU Orthodontic Clinic. A PMSTOP-Bang survey, as a component of the initial records appointment, was verbally
administered to the patient’s parents or guardian by the treating doctor (Figure 1). All doctors
were previously calibrated on how to appropriately use the 8-item screening questionnaire where
each “yes” answer was scored 1 point. In this study, a score of 3 and higher designated a high
risk for sleep apnea. This scale was chosen based on the findings of a previous study by Chiang
et al.19
Children 7-17 years of age without a history of previous orthodontic treatment and an
obstructive sleep apnea diagnosis were included in the study. Individuals with craniofacial
syndromes and skeletal asymmetries were excluded. At the initial exam appointment, patients
who were identified at high risk for POSA based on their PM-STOP-Bang scores were assigned
to the experimental group. Once a case was enrolled, an age-matched, low-risk patient with a
PM-STOP-Bang score of 2 and lower was assigned to the control group.
A total of 10 participants (n=5, experimental and n=5, control) were recruited into this
pilot study. Each patient was assigned a case number containing using a code such as Case 001
and Control 001. No individual identifying information was kept for the analysis. However, for
the direct benefit of the child, a key corresponding to each subject was retained on a secure VCU
Google drive so that any OSA diagnosis would allow for follow up and referral process.
8

Regardless of study enrollment decisions, patients identified by the PM-STOP-Bang
questionnaire at high risk for OSA were provided with referral to a primary care provider,
following the standard of care procedures for VCU Orthodontic Clinic.
During the recruitment process, it was explained that enrollment into the experimental
group would require two additional questionnaires (PSQ and PSC, Figure 2 and Figure 3) to be
completed as well as a one-night HSAT. A written and verbal consent/ assent was obtained from
all study participants. Parents and guardians were provided information about the at-home sleep
apnea test. An in-depth description of how to set up and use the portable sleep apnea device
(NOX-T3, version 1.0, Nox Medical USA, Suwanee, Georgia) was provided for the parents and
the patient. They were also asked to watch a short video, specifically created by the manufacturer
for the patient use of the sleep apnea device, demonstrating the hookup and takedown
procedures. This video was available to the public on the internet, and the participants were
provided with the link so they could watch it again at a later time if needed. A written transcript
of the video, as well as the original Nox-T3 instructions manual was provided as well.
Each HSAT kit included NOX-T3 home sleep testing device with abdomen cable
attached, the wrist oximeter and Velcro strap with the oximeter probe attached, two belts and a
nasal canula in a sealed plastic bag, bandages and tape to allow for better fastening of the device,
and the instructions manual. NOX-T3 portable sleep monitoring device records oro-nasal airflow
and oro-nasal sound, a pulse oximetry, heart rate and respiratory effort recorded with a chest belt
and a recording unit. These measures were used for diagnosis by a sleep physician who was
blinded to the study participants. The total apnea-hypopnea index (AHI), a measure of the
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severity of OSA, was then calculated and the case was classified as normal, mild, moderate, or
severe.
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Pediatric-Modified-STOP-Bang Questionnaire
Child’s Name: ____________________________

Date: __/__/__

Please circle the correct response.

S Snoring: Does the child snore during naps or at night?

YES

NO

T Tonsillar hypertrophy: Does the child have large tonsils?

YES

NO

O Sleep obstruction: Does the child experience sleep obstruction (choking or gasping)?

YES

NO

P Psychological/ Behavioral symptoms: Does your child have Attention Deficient
Hyperactivity Disorder (ADHD), Attention Deficient Disorder (ADD), Oppositional Defiant
Disorder (ODD), or daytime irritability?
B BMI percent: Does the child’s BMI percent fall into >85% or <5%? (*See conversion
table)
A Age: Is your child younger than 4 or older than 16?

YES

NO

YES

NO

YES

NO

N Neuro/Muscular disorder: Does your child have abnormalities of muscle tone that can
affect the airway?
G Genetic/ Congenital disorder: Does your child have a genetic or congenital disorder
(for example-Ehlers Danlos Syndrome)?

YES

NO

YES

NO

*Conversion Table for BMI

Figure 1: Pediatric-Modified-STOP-Bang
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Appendix: 1:
Pediatric Sleep Questionnaire: Sleep-Disordered Breathing Subscale
070129

Child’s Name: ______________________________
Person completing form: _____________________

Study ID #: ___________
Date:
____/____/____

Please answer these questions regarding the behavior of your child during sleep and wakefulness. The
questions apply to how your child acts in general during the past month, not necessarily during the past few
days since these may not have been typical if your child has not been well. You should circle the correct
response or print your answers neatly in the space provided. A “Y” means “yes,” “N” means “no,” and
“DK” means “don’t know.”
1. WHILE SLEEPING, DOES YOUR CHILD:
Snore more than half the time?…………………………………………. ………..Y
Always snore?
………………………………………………………………..Y
Snore loudly?
…………………………………………………………………Y
Have “heavy” or loud breathing? …………………………………….…………..Y
Have trouble breathing, or struggle to breathe? …………………….……………Y

N
N
N
N
N

DK
DK
DK
DK
DK

A2

2. HAVE YOU EVER SEEN YOUR CHILD STOP BREATHING DURING
THE NIGHT? ……………………………………………………………………….Y

N

DK

A7

3. DOES YOUR CHILD:
Tend to breathe through the mouth during the day?…………………………….Y
Have a dry mouth on waking up in the morning? ……………………………...Y
Occasionally wet the bed? ……………………………………………………...Y

N
N
N

DK
DK
DK

A24

4. DOES YOUR CHILD:
Wake up feeling unrefreshed in the morning? ………………………………….Y
Have a problem with sleepiness during the day? ………………….……….…...Y

N
N

DK
DK

B1

5. HAS A TEACHER OR OTHER SUPERVISOR COMMENTED THAT YOUR
CHILD APPEARS SLEEPY DURING THE DAY? …………………………….…Y

N

DK

B4

6. IS IT HARD TO WAKE YOUR CHILD UP IN THE MORNING? …………….…Y

N

DK

B6

7. DOES YOUR CHILD WAKE UP WITH HEADACHES IN THE MORNING?…..Y

N

DK

B7

8. DID YOUR CHILD STOP GROWING AT A NORMAL RATE AT
ANY TIME SINCE BIRTH? …………………………………………………….….Y

N

DK

B9

9. IS YOUR CHILD OVERWEIGHT? ………………………………………………...Y

N

DK

B22

10. THIS CHILD OFTEN:
Does not seem to listen when spoken to directly. ……………………………....Y
Has difficulty organizing tasks and activities. …………………….…………...Y
Is easily distracted by extraneous stimuli. ………………………….…………...Y
Fidgets with hands or feet or squirms in seat. ……………………………….....Y
Is “on the go” or often acts as if “driven by a motor”. …………………………Y
Interrupts or intrudes on others (eg., butts into conversations or games). ………Y

N
N
N
N
N
N

DK
DK
DK
DK
DK
DK

C3

A3
A4
A5
A6

A25
A32

B2

C5
C8
C10
C14
C18

© Regents of the University of Michigan 2006

Figure 2: Pediatric Sleep Questionnaire (PSQ)
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Appendix: 2
Child’s Name
Today's

Record Number
Filled out by

date

Today’s Date

_

_ _

_

Date of Birth

Pediatric Symptom Checklist
Emotional and physical health go together in children. Because parents are often the first to notice a problem with
their child’s behavior, emotions or learning, you may help your child get the best care possible by answering these
questions. Please mark under the heading that best fits your child.
Never

Sometimes

(0)
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.

Complains of aches/pains
Spends more time alone
Tires easily, has little energy
Fidgety, unable to sit still
Has trouble with a teacher
Less interested in school
Acts as if driven by a motor
Daydreams too much
Distracted easily
Is afraid of new situations
Feels sad, unhappy
Is irritable, angry
Feels hopeless
Has trouble concentrating
Less interest in friends
Fights with others
Absent from school
School grades dropping
Is down on him or herself
Visits doctor with doctor finding nothing wrong
Has trouble sleeping
Worries a lot
Wants to be with you more than before
Feels he or she is bad
Takes unnecessary risks
Gets hurt frequently
Seems to be having less fun
Acts younger than children his or her age
Does not listen to rules
Does not show feelings
Does not understand other people’s feelings
Teases others
Blames others for his or her troubles
Takes things that do not belong to him or her
Refuses to share

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35

(1)

Often

(2)

_

_

_

_
_

Total score
Does your child have any emotional or behavioral problems for which she/he needs help?
Are there any services that you would like your child to receive for these problems?

() N
() N

() Y
() Y

If yes, what services?

www.massgeneral.org/psychiatry/assets/PSC-35.pdf 16th
May, 2013

Figure 3: Pediatric Symptom Checklist (PSC)
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Page 1

Statistical Methods
All data from the three surveys were entered into a database on Research Electronic Data
Capture (REDCap) tools hosted at Virginia Commonwealth University. REDCap is a secure,
web-based software platform designed to support data capture for research studies.21 All data
from HSAT was analyzed by a sleep physician to determine the POSA status.
To determine the ability of the PM-STOP-Bang to detect high risk cases of sleep apnea,
the PM-STOP-Bang scores were compared to the results from the Pediatric Sleep Questionnaire
which is a validated instrument for identifying individuals at high risk for sleep apnea. To
determine the ability of the PM-STOP-Bang and the PSQ to identify high risk cases for sleep
apnea, the results from these two instruments were compared to the results of the HSAT. Patients
with an AHI >1.5 were considered to have sleep apnea. For all comparisons, sensitivity,
specificity, positive and negative predictive values and their 95% confidence intervals were
reported. The demographic and clinical characteristics were compared between the experimental
cases and HSAT results using Fisher’s Exact test. T-test was used to compare age between the
groups. Significance level was set at 0.05. SAS EG v.8.2 (SAS Institute, Cary, NC) for all
analyses.
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Results
A total of 10 patients were enrolled in the study. The patient demographics and clinical
characteristics are provided in Table 1. Five subjects were considered at high risk for POSA
based on the PM-STOP-Bang score and the other 5 individuals served as controls. The average
PM-STOP-Bang score for the at high-risk group was 3.4 and ranged from 3 to 4 (out of a total
possible 8 points) whereas the control group had an average score of 0.4 and ranged from 0 to 2.
Interestingly, there was a significant difference in the distribution of adequate and inadequate
transverse occlusion, with a higher percentage of inadequate transverse occlusion among those
individuals who were classified as at high risk (80% vs 0%; p-value = 0.0467).
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Table 1: Patient Demographics and Clinical Characteristics
Age (mean, SD)
Gender

Case (n, %)
14.4, 2.4

Control (n, %)
13.8, 2.3

0, 0
5, 100

3, 60
2, 40

Male
Female

P-value
0.6964

Classification

0.1667
0.2857

Class I
Class II
Class III

1, 20
1, 20
3, 60

2, 40
3, 60
0, 0

Transverse

0.0476
Adequate
Inadequate*

1, 20
4, 80

5, 100
0, 0

Plane Angle

0.5238

High**
4, 80
2, 40
Normal***
1, 20
2, 40
Flat****
0, 0
1, 20
*Inadequate transverse defined as presence of a posterior cross bite of more than 2 teeth, **High
plane angle FMA30 ***Normal plane angle defined as FMA between 21-29, ****Flat plane
angle FMA 20
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To determine the ability of the PM-STOP-Bang to identify individuals who are at high
risk for SRBD, the results of the PM-STOP-Bang questionnaire were compared to those of the
Pediatric Sleep Questionnaire (PSQ), which is the gold standard for determining individuals at
high risk for SRBD (Table 2). Of the 5 subjects previously determined at high risk from the PMSTOP-Bang questionnaire, only four were also considered high risk from PSQ. Of the
individuals who were deemed not at risk based on the PM-STOP-Bang scores (n=5, control), 2
were identified at high risk from PSQ. The PM-STOP-Bang had a sensitivity of 67% (95% CI:
29%, 100%) and a specificity of 75% (95% CI: 33%, 100%) for identifying high risk individuals.
Furthermore, the positive and the negative predictive values were of 80% (95% CI: 45%, 100%)
and 60% (95% CI: 17%, 100%), respectively.

Table 2: Accuracy of PM-STOP-Bang at Identifying Cases High Risk for Sleep Apnea Identified
by Pediatric Sleep Questionnaire

PSQ: High
Risk for
Sleep Apnea

PM-STOPBang

Yes
Yes 4

No
1

Estimate % (95% CI)
Sensitivity

67 (29,100)

PPV

80 (45, 100)

No 2
3
Specificity 75 (33,100)
NPV
60 (17, 100)
*HSAT: Home Sleep Apnea Test; PSQ: Pediatric Sleep Questionnaire, PPV: Positive Predictive
Value; NPV: Negative Predictive Value
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The results of the home sleep apnea test are provided in Table 3 and 4. A board-certified
sleep specialist completed the analysis of the data captured from the one-night home sleep study
for all 10 participants. Based on their Apnea-Hypopnea Index (AHI), three of the 10 subjects
(Cases 1, 2, and 4) were recorded with sleep apnea diagnosis by the sleep physician. An AHI of
greater than 1.5 was used for the diagnosis of sleep apnea. Case 3 was presumptively normal.
However, this case was included in the table due to the significant increase in supine sleeping
time.
All of these 3 subjects were also classified as individuals at high risk for OSA based on
their PM-STOP-Bang scores. Comparing the PM-STOP-Bang to the HSAT results, the PMSTOP-Bang had a sensitivity of 100% (95% CI: 100%, 100%) and a specificity of 71% (95% CI:
38%, 100%). The positive predictive value was 60% (95% CI: 17%, 100%) and negative
predictive value was 100% (95% CI: 100%, 100%). Surprisingly, the previously validated PSQ
identified only 2 of these three individuals at high risk for sleep apnea when in fact all three were
diagnosed with POSA with the HSAT. The PSQ also detected an additional 4 subjects at high
risk who were not confirmed by HSAT as sleep apnea cases (False positive). The PSQ sensitivity
was 67% (95% CI: 13%, 100%) and specificity 43% (95% CI: 6%, 80%). The PSQ positive
predictive value was 33% (95% CI: 0%, 74%) and negative predictive value 75% (95% CI: 33%,
100%).
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PMSTOPBang

Table 3: Accuracy of PM-STOP-Bang and Pediatric Sleep Questionnaire (PSQ) for Detecting
Sleep Apnea Cases Identified by Home Sleep Apnea Test
HSAT
(AHI>1.5)
Yes
No
Estimate % (95% CI)
Yes 3
2
Sensitivity
100 (100, 100) PPV
60 (17, 100)
No

0

5

Specificity

71 (38,100) NPV

100 (100, 100)

Sensitivity

Estimate % (95% CI)
67 (13, 100) PPV

33 (0, 71)

PSQ

HSAT
(AHI>1.5)
Yes

Yes
2

No
4

No
1
3
Specificity
43 (6, 80) NPV
*HSAT: Home Sleep Apnea Test; AHI: Apnea-Hypopnea index; PSQ: Pediatric Sleep
Questionnaire; PPV: Positive Predictive Value; NPV: Negative Predictive Value

75 (33, 100)

Table 4: Analysis from Sleep Professional
Case 1
Mildly abnormal, suggests mild OSA, hypopnea dominant + Increase in
supine time (limited saturation data - may underestimate)
Case 2:
Mildly abnormal, suggests mild OSA, increase in supine time (limited
saturation data - may underestimate)
Case 3:
Case 4:

Presumptively normal, increase supine time, (limited saturation data - may
underestimate)
Mildly abnormal, suggests mild OSA, (limited saturation data - may
underestimate).
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Each study subject also completed the Pediatric Symptoms Checklist (PSC) and 2 of the
10 subjects met criteria for high risk for emotional or behavioral problems (PSC score>28). Both
of these subjects were also identified at high risk for SDBDs based on their PSQ score. However,
these subjects were not confirmed as cases with sleep apnea by the physician based on their
home sleep apnea test. Interestingly, the PM-STOP-Bang test did not identify these patients at
high risk either indicating the ability of the new questionnaire in correctly identifying the true
negative cases.
The associations between the patient characteristics and the results of the home sleep
apnea test are provided in Table 5. There was no significant association between POSA
diagnosis with HSAT for any demographic or orthodontic characteristics evaluated. Specifically,
there was no significant difference associated with age, gender, molar classification, presence of
transverse discrepancy, or plane angle and the diagnosis of POSA. However, when comparing
the cases and controls enrolled in the study, the individuals at high risk (cases based on a PMSTOP-Bang score of 3 and higher) had a statistically significant tendency to have inadequate
transverse dimension.

20

Table 5: The Associations between Patient Characteristics and Results of Home Sleep Apnea
Test (HSAT)
Yes (AHI>1.5)
No (AHI<1.5)
Age (mean, SD)
15.7, 2.3
13.4, 2.0
Gender
Male
0, 0%
3, 43%
Female
3, 100%
4, 57%
Classification
Class I
1, 33%
2, 29%
Class II
0, 0%
4, 57%
Class III
2, 67%
1, 14%
Transverse
Adequate
1, 33%
5, 71%
Inadequate*
2, 67%
2, 29%
Plane Angle
High**
2, 67%
4, 57%
Normal***
1, 33%
2, 29%
Flat****
0, 0%
1, 14%
*Inadequate transverse defined as presence of a posterior cross bite of more than 2 teeth, **High
plane angle FMA30 ***Normal plane angle defined as FMA between 21-29, ****Flat plane
angle FMA 20
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P-value
0.1563
0.4750

0.2000

0.5000

>0.999

Discussion
The purpose of screening tests is to detect the presence of a disease in a subject. Based on
the results of these tests, clinicians make decisions for further testing or treatment options. The
four important measures for the reliability of these tests are sensitivity (true positive), specificity
(true negative), positive predictive value (the percent of positive tests that are truly positive), and
negative predictive value (the percent of negative tests that are truly negative). The current
research aimed to validate the PM-STOP-Bang questionnaire for its use as a sleep apnea
screening tool in a dental clinic setting, in orthodontics or pediatric dentistry. Specifically, its
sensitivity, specificity, positive predictive value, and negative predictive value were investigated.
There are several tools that can be used to screen for SRBD and POSA. One reliable tool
is the previously validated Sleep Related Breathing Disorder scale (SRBD scale), a subscale of
the PSQ. This is a 22-item questionnaire that explores behavior, breathing, sleepiness, and other
important signs of the disorder. It is designed to take 5-7 minutes to complete and a positive
response to more than 7 questions indicates possibility of OSA. When compared with the PSG
data, the PSQ instrument was previously reported to achieve a sensitivity of 85% and a
specificity of 87% for identifying SRBD in children ages 2-18.16
Similarly, the Children’s Sleep Habits Questionnaire is a 35-item parent-reported
screening tool designed to assess behavioral and medically based sleep problems in school
children.22 In this 8 sleep-domain survey, each answer is scored on a 1 to 3 point scale.
According to Owens et al., 22 this screening test has a sensitivity and a specificity of 80% and
72%, respectively, for the diagnosis of SRBD in children 4-10 years old.
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Finally, another tool is the Sleep Disordered Inventory for Students which has 35 to 40
questions designed to determine if a child or adolescent has a high probability of a major sleep
disorder requiring treatment.23 This screening tool was reported to have a good sensitivity for
children and adolescents (81% and 82%, respectively) and a very high specificity (91% and 95%,
respectively) for identifying children and adolescents who would need a referral to a sleep
specialist.23
In children, a common manifestation of pediatric obstructive sleep apnea is hyperactivity.
Unfortunately, about 25% of children diagnosed with ADHD actually have undiagnosed POSA.
In 2007, despite the PSQ being deemed as a reliable screening tool, to further validate this
questionnaire, Chervin et al.24 also utilized behavioral and cognitive testing with the Child
Symptoms Inventory-4: Parent Checklist. This was done in an effort to screen for hyperactivity
or emotional changes to behavior that may be due to an undiagnosed SRBD. This previously
validated Child Symptom Inventory contains 108 items that screen children aged 5 to 12 years
for a variety of emotional and behavioral disorders based on the Diagnostic and Statistical
Manual of Mental Disorders, 4 Edition, (DSM-IV). Similarly, in the current study, to assess
various emotional and various behavioral disorders related to POSA, the Pediatric Symptom
Checklist (PSC) was administered. The PSC with only 35-item screening questionnaire can be
easily completed by parents as opposed to 108 question survey. Furthermore, it is designed to
help pediatricians in an outpatient setting identify school-age children with difficulties in
psychosocial functioning. The PSC is a previously validated tool with a specificity of 68% and a
sensitivity of 95% when compared to pediatrician ratings.25 As stated earlier, unlike adults, some
children with obstructive sleep apnea may exhibit hyperactivity in behavior. Therefore, it was
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thought that the PSC may possibly be used as a shorter adjunct tool for dental clinicians to use
when screening for POSA if there is a suspected behavior manifestation of the disorder. It was
considered that a positive score may allow for increased ability to capture high risk children for
the disease and make appropriate referrals to a sleep physician. In a similar thought process,
screening with the PSC may also help identify children early enough to prevent a misdiagnosis
of ADHD. In an effort to evaluate the merits of using the PSC as an adjunct screening tool that is
sensitive enough to notice these behavior manifestations of POSA, PSC was completed for all
study participants for statistical evaluation.
While all of these surveys are designed to be simple, the large number of items and
various scoring protocols make them difficult and impractical to complete in a busy clinical
setting. Additionally, none of these questionnaires take into account the physical or craniofacial
characteristics such as a retrognathia or enlarged tonsils. As mentioned previously,
approximately 4% of children have sleep apnea.4 However, the majority of children remain
undiagnosed because screening for POSA is challenging due to the complexity of in-center
polysomnography tests. Therefore, the availability of a simple yet reliable screening
questionnaire in an orthodontic clinic may help orthodontists to identify patients at risk and make
early referrals to the appropriate physician.
The STOP-Bang has only 8 questions that can easily be answered and scored. Therefore,
it may serve as a simple yet effective screening tool for OSA in a busy dental setting. Previous
studies have reported high sensitivity (83.6%, 92.9% and 100% for mild, moderate and severe
OSA, respectively) and moderate specificity for STOP-Bang to reliably detect sleep apnea in
adults.18 However, in a population younger than 18 years of age, the instrument was shown to
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exhibit low sensitivity, and therefore, the STOP-Bang was not recommended when screening
children for POSA.26 Instead, the PM-STOP-Bang was modeled after the STOP-Bang screening
questionnaire and the physical manifestations of pediatric high-risk markers of the disorder were
taken into consideration.19 For example, enlarged tonsils, considered to be the most common site
of obstruction in children, was included in this modified version of STOP-Bang.5,19
The purpose of the current study was to evaluate the ability of the PM-STOP-Bang to
identify high-risk children for POSA by comparing the results of the new questionnaire to those
of the previously validated gold standard PSQ and a one-night home sleep test. When compared
to the PSQ findings, the PM-STOP-Bang had a moderate sensitivity of 67% and moderate
specificity of 75% for identifying high risk individuals. However, when the PM-STOP-Bang
results were compared to those of the HSAT, the new screening tool was shown to be highly
sensitive (100%) and moderately specific (76%) in the identification of patients at high risk for
OSA.
Surprisingly the gold standard screening tool PSQ accurately identified only 2 of the 10
patients at high risk who were later confirmed to have POSA with the sleep test. However, PSQ
missed 1 patient who actually had the disease. Additionally, the PSQ incorrectly identified 4
participants as high-risk for POSA while the PM-STOP-Bang incorrectly identified only 2
participants. Overall, the PSQ yielded a sensitivity of 71% and a specificity of 43%. On the other
hand, the PM-STOP-Bang accurately identified all 3 subjects out of 10 at risk who were later
shown to have POSA (a sensitivity of 100%). Therefore, the most remarkable result to emerge
from the data was the higher sensitivity and specificity of the PM-STOP-Bang than that of PSQ.
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A secondary aim of the study was to evaluate the ability of the PSC to be used as an
adjunct screening tool for SRBD. In children, a common manifestation of POSA is hyperactivity.
Unfortunately, about 25% of children diagnosed with ADHD actually have undiagnosed POSA.
In 2007, despite the PSQ being deemed as a reliable screening tool, to further validate this
questionnaire, Chervin et al.24 also utilized behavioral and cognitive testing with the Child
Symptoms Inventory-4: Parent Checklist. This was done in an effort to screen for hyperactivity
or emotional changes to behavior that may be due to an undiagnosed SRBD. This previously
validated Child Symptom Inventory contains 108 items that screen children aged 5 to 12 years
for a variety of emotional and behavioral disorders based on the Diagnostic and Statistical
Manual of Mental Disorders, 4th Edition, (DSM-IV).
In the current study, to assess various emotional and behavioral disorders related to
POSA, the Pediatric Symptom Checklist (PSC) was administered. The PSC with only 35-item
screening questionnaire can be easily completed by parents as opposed to 108 question survey.
Furthermore, it is designed to help pediatricians in an outpatient setting identify school-age
children with difficulties in psychosocial functioning. The PSC is a previously validated tool
with a specificity of 68% and a sensitivity of 95% when compared to pediatrician ratings.25 As
stated earlier, unlike adults, children with obstructive sleep apnea may exhibit hyperactivity in
behavior. Therefore, it was thought that the PSC may possibly be used as a shorter adjunct tool
for dental clinicians to use when screening for POSA if there is a suspected behavior
manifestation of the disorder. It was considered that a positive score may allow for increased
ability to capture high risk children for the disease and make appropriate referrals to a sleep
physician. In a similar thought process, screening with the PSC may also help identify children
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early enough to prevent a misdiagnosis of ADHD. In an effort to evaluate the merits of using the
PSC as an adjunct screening tool that is sensitive enough to notice these behavior manifestations
of SRBD, PSC was completed for all study participants for statistical evaluation.
According to the PSC results of the current study, 2 of the 10 subjects were identified at
high risk based on their reported emotional or behavioral problems (PSC score>28). Both of
these subjects were also at high risk for SRBD based on the PSQ instrument. However, neither
subject had a PM-STOP-Bang score of 3 or higher nor was either positive for sleep apnea based
on the home sleep apnea test. Therefore, it is plausible to conclude that with a high false positive
rate, the PSC is not reliable to use as an adjunct in evaluating SRBD.
Maxillary morphological differences were previously reported between OSA and control
subjects, indicating a potential etiological role in OSA.27 However, the relationship between
maxillary constriction and the etiology of OSA is not clear. Also, although the posterior
transverse discrepancy and its effects on OSA have not been shown, statistically significant
differences in palatal heights between OSA and control subjects have been previously reported.27
Interestingly, within its limitations, this study reported posterior transverse discrepancy for 4 of
the 5 patients who were also identified as “high risk” with the PM-STOP-Bang questionnaire.
Furthermore, there was a significant difference in the distribution of adequate and inadequate
transverse occlusion, with a higher percentage of inadequate transverse occlusion among those
who were classified as POSA cases from the PM-STOP-Bang. However, the comparison of the
demographic and orthodontic characteristics to the HSAT results did not show any statistically
significant association. It is possible that due to the small sample size, the relationship between
the maxillary morphological factors and the sleep apnea was not determined.
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In future studies with a large sample size, in addition to administering the questionnaire,
it would be useful to record clinical findings of malocclusion to assess a possible relationship
between the presence of POSA and malocclusion, and its related features such as Class II
malocclusion with a retrognathic mandible. If an association is present, then the PM-STOP-Bang
instrument should be modified to include an additional question about clinical presentation,
specifically maxillary and mandibular morphology such as retrognathic chin.
There were several limitations to the study. The most important limitation of the study
was the small sample size. Due to the single center design, there was a possible sample selection
bias. Also, although the study aimed to enroll 15 cases and 15 controls, due to COVID-19
closures, the number of subjects recruited were only 5 cases and 5 controls. The study had an
IRB approval to begin in January of 2020 but was halted when clinics closed in March of 2020.
The graduate orthodontic clinic did not re-open until July 2020. Furthermore, patients with
urgent orthodontic needs were given priority when scheduling appointments for the opening.
Finally, new patients were not accepted to the clinic for several months. Therefore, the actual
predetermined number of subjects could not have been recruited. A future study with a larger
sample size is warranted to validate the PM-STOP Bang as a potential screening instrument for
accurately identifying children at high risk for sleep apnea.
An additional limitation of the study was regarding the use of the NOX-T3 home sleep
monitor device in this sample population. While overall, the patients were able to use the device,
some pulse oximetry data was limited. Also, the traditional pulse oximeter for children in this
sample was found to be a significant challenge for compliance; therefore, in future studies the
use of a wrist only HSAT would be a better option. Additionally, because the study sample
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consisted of children, there were some subjects who turned off the device too soon. Although
four hours of data recording was requested, two subjects completed only 3 hours and 30 minutes
of sleep time. Therefore, for more definitive diagnosis, it would be ideal to repeat the HSAT
testing with a different device preferably with a wrist pulse oximeter so that strict adherence to
required sleep time (at least 4 hours) would be achieved.
In summary, the current study showed promising results that if administered in dental
offices, the PM-STOP-Bang questionnaire may be an easy and reliable screening tool for the
identification of pediatric patients at high risk for sleep apnea. Future studies with increased
sample size and longer home sleep recording data are warranted.
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Conclusion
Within its limitation the current study indicated that the PM-STOP-Bang with a
sensitivity of 100% and a specificity of 71%, when compared with HSAT, may, one day be an
alternative to the PSQ, a validated instrument.
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